Abstract
The present study aimed to develop Eberconazole nitrate (EBZ)-loaded ethosomes using Central Composite Design (CCD) by the cold method. The three-factor CCD model was implemented to investigate the effect of variables on ethosome characteristics and performance. For CCD modelling, dependent and independent variables were chosen. The percentage of soy phosphatidylcholine (PC) (X1; % w/v), ethanol (X2; % v/v), and Propylene glycol (PG) (X3; % v/v) were designated as independent variables. However, the dependent variables were particle size (Y1; nm), polydispersity index (PDI) (Y2), and encapsulation efficiency (EE) (Y3; %). The level of independent variables was changed to produce a total of 17 batches (F1-F17). Formulation code F2 with particle size; 227.9 nm, PDI; 0.160 and % EE; 90 ± 0.34 % was selected as the optimized batch. The optimized batch was further incorporated into the hydrogel matrix and investigated for several physicochemical parameters. When compared to the free drug-loaded hydrogel, the ethosomes-loaded hydrogel demonstrated controlled EBZ release with higher skin permeation and skin retention of EBZ. The assessment of antifungal efficacy of the developed formulation was carried out by in vivo animal model method. In vivo studies demonstrated that EBZ-loaded ethosomal gel may alleviate fungal infection caused by a resistant strain of Candida albicans. The study showed satisfactory results, which suggest the suitability of the developed formulation for the effective treatment of fungal infection.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.